Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health In TechHIT -0.97%19 EV-to-EBITDA is -14.80 as of Aug. 20, 2026. GuruFocus rates HIT with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 1,965 Software companies, Health In Tech ranks worse than 50890.53% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Health In Tech's enterprise value is $60.51 Mil.
Health In Tech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $-4.09 Mil. Therefore, Health In Tech's EV-to-EBITDA for today is -14.80.
The historical rank and industry rank for Health In Tech's EV-to-EBITDA or its related term are showing as below:
HIT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -727.23 Med: 25.6 Max: 198.89
Current: -14.8
During the past 4 years, the highest EV-to-EBITDA of Health In Tech was 198.89. The lowest was -727.23. And the median was 25.60.
HIT's EV-to-EBITDA is ranked worse than 100% of 1965
companies
in the Software industry
Industry Median: 10.39
vs HIT: -14.80
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Health In Tech's PE Ratio (TTM) for today is calculated as:
Health In Tech's share price for today is $1.02.
Health In Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.070.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Health In Tech's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Application subindustry, Health In Tech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health In Tech EV-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Health In Tech's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Health In Tech's EV-to-EBITDA falls into.
Health In Tech's current Enterprise Value is $60.51 Mil.
Health In Tech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.09 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health In Tech (HIT) has a EV-to-EBITDA of -14.80 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Health In Tech. According to the industry distribution chart, Health In Tech ranks #999999 out of 1965 companies in the Software industry.
Is Health In Tech's EV-to-EBITDA too high?
Health In Tech's current EV-to-EBITDA is -14.80. Based on the distribution chart, Health In Tech ranks #999999 out of 1965 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Health In Tech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Health In Tech's EV-to-EBITDA compare to AEYE and IDN?
According to the Software industry distribution chart, Health In Tech ranks #999999 out of 1965 companies for EV-to-EBITDA. This places Health In Tech in the lower half of its industry. The industry median EV-to-EBITDA is 10.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Software company?
The median EV-to-EBITDA among Software companies is 10.39, based on 1,965 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Health In Tech. For the Software industry, the median EV-to-EBITDA is 10.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health In Tech's current EV-to-EBITDA is -14.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health In Tech stock overvalued right now?
Health In Tech (HIT) has a current EV-to-EBITDA of -14.80. The current EV-to-EBITDA is -14.80. Health In Tech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Health In Tech (HIT), the current EV-to-EBITDA is -14.80 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
19GF Score
Get the complete analysis for HIT
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIT has been successfully added to your 
